Stock 1302 LIFETECH SCIENTIFIC CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages LifeTech Scientific Corporation

Equities

1302

KYG548721177

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:09 16/05/2024 BST 		5-day change 1st Jan Change
1.89 HKD -2.07% Intraday chart for LifeTech Scientific Corporation +9.88% -19.57%
12:07pm LifeTech Scientific Completes Follow-up of Phase 2 Clinical Study of IBS Coronary Scaffold MT
05-15 LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
LifeTech Scientific Completes Follow-up of Phase 2 Clinical Study of IBS Coronary Scaffold
LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
Lifetech Scientific Buys Shares For Employee Incentive Scheme
Lifetech Scientific Unit Invests 340 Million Yuan in Structured Deposits
Lifetech Scientific Books Lower 2023 Profit Despite Surge in Revenue
LifeTech Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
LifeTech Scientific Flags Significant Profit Drop in 2023
Lifetech Scientific Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
LifeTech Scientific to Grant 174.8 Million Share Options
LifeTech Scientific Gets Regulatory Nod to Register Peripheral Thrombus Aspiration Catheter
LifeTech Scientific's H1 Attributable Profit Grows on Higher Revenue
LifeTech Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
Epione Surgical Navigation System Obtained Official Registration Approval by the China NMPA
LifeTech Scientific Unit Invests 50 Million Yuan in Structured Deposit Product by Bank of Ningbo
LifeTech Scientific Completes Patient Enrollment for Phase 3 Study of Coronary Scaffold System
Lifetech Scientific Corporation Announces Enrollment in the Phase Iii Clinical Study of Ibs®? Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed
LifeTech Scientific Corporation Announces Publication of the Three-Year Follow-Up Results of FIM Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
LifeTech Scientific Logs 68.6% Drop in 2022 Profit
LifeTech Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Lifetech Scientific and Jenscare Scientific to Cooperate on Business Development
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1302 Stock
  4. News LifeTech Scientific Corporation
  5. Other languages